Cargando…
Selective serotonin reuptake inhibitors increase risk of upper gastrointestinal bleeding when used with NSAIDs: a systemic review and meta-analysis
The use of selective serotonin reuptake inhibitors (SSRIs) can increase the risk of gastrointestinal (GI) bleeding. Similarly, it is well known that the use of NSAIDs predisposes patients to upper GI bleeding. The aim of this study was to explore if the addition of SSRIs in patients already taking N...
Autores principales: | Alam, Syed Mobashshir, Qasswal, Mohammed, Ahsan, Muhammad Junaid, Walters, Ryan W., Chandra, Subhash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402708/ https://www.ncbi.nlm.nih.gov/pubmed/36002638 http://dx.doi.org/10.1038/s41598-022-18654-2 |
Ejemplares similares
-
Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy
por: Kumar, Deepak, et al.
Publicado: (2009) -
Selective Serotonin Reuptake Inhibitors and Gastrointestinal Bleeding: A Case-Control Study
por: Carvajal, Alfonso, et al.
Publicado: (2011) -
Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
por: Straube, Sebastian, et al.
Publicado: (2009) -
Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes
por: Köhler, Ole, et al.
Publicado: (2015) -
Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link
por: Patel, Harish, et al.
Publicado: (2015)